KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 97 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $73,621,831 | -0.7% | 6,249,731 | 0.0% | 4.69% | +33.0% |
| Q1 2024 | $74,121,810 | +47.8% | 6,249,731 | +52.7% | 3.53% | +2.5% |
| Q4 2023 | $50,135,955 | +78.5% | 4,092,731 | +40.3% | 3.44% | +16.3% |
| Q3 2023 | $28,087,503 | +7.0% | 2,916,667 | 0.0% | 2.96% | -29.6% |
| Q2 2023 | $26,250,003 | +14.5% | 2,916,667 | 0.0% | 4.20% | -6.2% |
| Q1 2023 | $22,925,003 | +16.3% | 2,916,667 | 0.0% | 4.48% | +34.7% |
| Q4 2022 | $19,716,669 | – | 2,916,667 | – | 3.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,579,490 | $20,146,000 | 22.25% |
| Novo Holdings A/S | 2,901,927 | $22,664,000 | 2.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 322,436 | $2,518,000 | 0.96% |
| Vivo Capital, LLC | 300,325 | $2,346,000 | 0.69% |
| VHCP Management II, LLC | 221,651 | $1,635,000 | 0.67% |
| RA Capital Management | 591,070 | $4,616,000 | 0.57% |
| INTERWEST VENTURE MANAGEMENT CO | 329,942 | $2,577,000 | 0.55% |
| Eventide Asset Management | 98,100 | $766,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,665 | $169,000 | 0.03% |
| A.R.T. Advisors, LLC | 11,116 | $86,000 | 0.00% |